Latest filing published 23 Sept 2021 for Revelation Biosciences, INC., €43.
First 200 filings with a declared amount
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Glazer Capital, LLC is a declared insider at 56 companies; the most frequent names are FAST Acquisition Corp., Longevity Acquisition Corp and Romeo Power, Inc. Over a trading history stretching from 6 November 2018 to 23 September 2021, the count stands at 538 filings.
In open-market terms, that means 4 purchases worth €1.1M on one side and 518 sales worth €452.1M on the other. The net balance comes to €451.0M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants. Since January 2021: no purchases and 161 sales on the market.
Half of the purchases are above €83k and half below. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
On 23 September 2021 came the latest disclosure, an open-market sale for €43 in Revelation Biosciences, Inc. The last purchase on record was published on 4 December 2020, which is 2,149 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 531 declarations